You need Adobe Acrobat Reader to be able to view the PDF files. You may already have it installed.
If not you can download it from the Adobe website here or by clicking on the graphic.
The Influence of glomerülar fIltratIon rate In outcomes of drug-elutIng stents ImplantatIon In patIents wIth coronary artery dIsease and chronIc kIdney dIsease
Batyraliev T, Shulzhenko L, Arystanova A, Pershukov I, Fettser D, Sidorenko B, Avşar Ö, Sadykov T, Belenkov Y.
The role of reduce of glomerular filtration rate in outcomes of drug-eluting stents implantation in patients with ischemic heart disease and chronic kidney disease.
In this study were consecutively included 432 patients who in 2005 have undergone percutaneous coronary intervention (PCI) with one or more drug - eluting stent implantation. Included in the study patients were divided into 3 groups by the glomerular filtration rate (GFR): group 1 - 271 patients with GFR > 60 ml/min/1,73m2, group 2 - 132 patients with GFR between 30 and 60 ml/min/1,73m2, and group 3 consisted of 29 patients with GFR less than 30 ml/min/1,73m2. In all the patients only used contrast agent Iodixanol, and the prevention of contrast-induced nephropathy (CIN) was performed without fail. The immediate success of PCI was high and comparable in all groups. The frequency of CIN was significantly higher in groups 2 and 3 (6,8% and 17,2% against 0,7% in group 1, p <0,001). Within 12 months of observation the frequency of restenosis was higher in groups 2 and 3: 15,9% and 27,6% against 6,6% in group 1 (p <0,001). Reduced GFR was a predictor of long-term up to 3 years mortality in patients with CKD, where as for group 2 compared with group 1 the relative risk (RR) of death = 1.77 (95% CI 1,19 ÷ 3,74; p = 0.001), and for group 3 compared with group 1 RR of death = 3.69 (95% CI 1,58 ÷ 6,87; p = 0.001). In addition decreased GFR was a predictor of nonfatal MI within 3 years: for group 2 vs. group 1 RR = 1.69 (95% CI 1,12 ÷ 3,07; p = 0.009) and group 3 vs. group 1 RR = 3.44 (95% CI 1,37 ÷ 6,19; p = 0.001).
The study showed that the initially reduced GFR after stenting increases the risk of CIN, leads to an increase in the frequency of restenosis and repeated revascularization up to 12 months, and is a predictor of long-term death and nonfatal MI up to 3 years.
Gümrükçüoğlu A.H, Akdağ S, Şimşek H, Şahin M, Tuncer M.
We evaluated the clinical, angiographic aspects and hospital mortality in patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI).
The study included 248 consecutive patients (172 males, 76 females; mean age 59,3±11,6 years) who underwent PCI for STEMI within twelve hours after the onset of symptoms. PCI (balloon angioplasty and / or stent placement) was performed only infarct related artery. The procedural success in acute phase defined as stenos falling below 50% and TIMI III flow in infract related artery.
Primary PCI was done 248 patients with STEMI at 2010. The most frequent risk factors for coronary artery disease were cigarette smoking and hypertension. The most common anatomic localization of STEMI was anterior. Success rate was 95.8% for primary PCI. Mortality occurred in 15 (5,8%) patients STEMI.
As a result, primary PCI reperfusion therapy provides a significant reduction in deaths when used with app-ropriate timing. Better use of reperfusion strategies in national and regional more efforts requirement.
Key Words: Primary percutaneus coronary intervention, SE elevation myocardial infarct
EchocardIographIc evaluatIon of left ventrIcular systolIc and dIastolIc functIons wIth usIng a novel Index
Sürücü H, Okudan S, Değirmenci A, Boz H, Ertürk M, Tatlı E.
We aim to investigate the clinical significance of a new index that evaluates systolic and diastolic functions together in left ventricular diastolic dysfunction (LVDDF).
Cases were divided into four groups according to their left ventricular (LV) inflow and pulsed wave tissue Doppler imaging (pw-TDI). Group 1 (n=112) represented normal diastolic LV inflow while group 2 (n=128) represen-ted impaired LV relaxation, group 3 (n=46) represented pseudonormalization and group 4 (n= 15) represented reversible restrictive LVDDF. We defined a new index (novel index=Ea-Aa/Sa) by using the pw-TDI parameters taken from LV basal-lateral annulus and subtracting late (Aa) velocity from early (Ea) velocity and dividing it by systolic (Sa) velocity. Among the index that evaluate systolic and diastolic functions together, novel index and Tei index were lower in group 1 (control group) compared to other groups. However, while Tei index was not different among the patients with LVDDF, novel index was different. Novel index was lower in group 4 compared to group 1, 2, and 3 (respectively p<0.001, p<0.001, p=0.025). And also, it was lower in group 3 compared to group 2 (p= 0.033). Another prominent correlation was found between novel index and non-invasively estimated pulmonary capillary wedge pressure (PCWP). Novel index was negatively associated with PCWP alterations (correlation rate= 43 %, p<0.001).
We concluded that novel index may be useful a diagnostic tool to detection of LVDDF. While Tei index was not different among the patients with LVDDF, novel index was sensitive to determine all of LVDDF.
Key Words: Left ventricular systolic and diastolic functions, Pulsed wave tissue Doppler, Novel index
EvaluatIon of vIable myocardIum at rIsk: Current Status
Karan A, Aras D, Topaloğlu S, Korkmaz Ş.
The frequency of ischemic heart failure is increasing in developed and developing countries. Patients suffe-ring from this disease have poor prognosis despite recent advances in several therapies. It is showed that revascula-rization improves clinical outcomes in these patients with viable myocardium. In contrast patients without viable tissue do not benefit from revascularization. Therefore assesment of myocardial viability is very important for a selection of candidates for revascularization. Several modalities have been developed to evaluate viable and nonviable myocardium. In this review, current status and future expectations in these techniques and their value for the prediction of left ventricular regional and global function, in exercise capacity and long-term prognosis are discussed.
A case of ruptured aneurysm of gIant sInus valsalva
Akar Bayram N, Baştuğ S, Sarı C, Durmaz T, Keles T, Hıdıroğlu M, Erdoğan Ş.K, Bozkurt E.
Rupture aneurysms of sinus valsalva are relatively rare lesions and usually may cause manifestations of prompt onset. In this case rupture aneurysm of sinus valsalva is diagnosed with echocardiography. We presented a 29 years old Afghan man with effort dyspnea, fatigue, shortness of breath and chest pain for ten years.
PERCUTANEOUS INTERVENTION for subklavIan artery stenosIs: A case report
Orçun S, Klılıç H, Akdemir R.
We report a case of subclavian artery stenosis treated with percutaneous angioplasty. A 35-year-old woman with hypertension presented with different blood pressure in each arm. Angiography showed severe stenosis (%99) of the left subclavian artery proximal.
Stenotic lesion was crossed by using a 0.014 inch 260 cm long guidewire. The 8x40mm stent was placed over the lesion. Control angiography shown that dissection of the left subclavian artery before the lesion. After 8x40mm second stent was placed over the dissection. Control angiographic study depicted opening of the segment which had dissection and good arterial flow toward the left subclavian and vertebral artery. However, left internal mamarian artery was occluded after placed of second stent. Patient had a little chest pain due to LIMA occlusion. Although it is not an important problem with the exception of patient will undergo coronary bypass surgery in the future, it was bitter for us that patient had chest pain after the intervention. LIMA should been prevent if dissection occur during the procedure.
FONDAPARINUX FOR THE THERAPY of a patIent wIth heparIn-INDUCED THROMBOCYTOPENIA durIng admInIstratIon of unfractIonated heparIn due to transvenous pacIng: A case report
Karan A, Tuna Başyiğit F, Malçok Gürel Ö, Topaloğlu S, Aras D,
Two distinct types of heparin-induced thrombocytopenia (HIT) have been defined. Type I HIT is a non-immunemediated side effect. In contrast type II HIT is an immune-mediated life-threatening complication. Direct thrombin inhibitors such as lepirudin and argatroban approved by FDA for treating patients with HIT have been studied. Although fondaparinux-a selective, synthetic factor Xa inhibitor- lacks FDA approval for his indication, case reports and series published up to date contribute to growing evidence about it. In this case report, we represented a 77 year-old man with atrioventricular block who had been developed HIT in the course of unfractionated heparin infusion for transient pacemaker and aimed to review current status about the usage of fondaparinux in this patients.